Equities

Uscom Ltd

UCM:ASX

Uscom Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.045
  • Today's Change0.004 / 9.76%
  • Shares traded3.84k
  • 1 Year change--
  • Beta-0.9829
Data delayed at least 20 minutes, as of Nov 15 2024 02:34 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Uscom Ltd grew revenues 38.73% from 2.72m to 3.77m while net income improved from a loss of 2.59m to a smaller loss of 2.07m.
Gross margin83.80%
Net profit margin-54.99%
Operating margin-61.92%
Return on assets-40.23%
Return on equity-67.97%
Return on investment-53.05%
More ▼

Cash flow in AUDView more

In 2024, Uscom Ltd increased its cash reserves by 15.66%, or 341.17k. Cash Flow from Financing totalled 1.57m or 41.69% of revenues. In addition the company used 1.16m for operations while cash used for investing totalled 57.55k.
Cash flow per share-0.0096
Price/Cash flow per share--
Book value per share0.0125
Tangible book value per share0.0108
More ▼

Balance sheet in AUDView more

Uscom Ltd appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio3.02
Quick ratio2.54
Total debt/total equity0.3232
Total debt/total capital0.2443
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.